Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats.
Gracie L HaySarah J BaraczNicholas A EverettJessica RobertsPriscila A CostaJonathon C ArnoldIain S McGregorJennifer L CornishPublished in: Journal of psychopharmacology (Oxford, England) (2018)
This is the first demonstration that cannabidiol can reduce the motivation to seek and consume methamphetamine, and suggests that cannabidiol might be worth trialing as a novel pharmacotherapy for methamphetamine dependence.